Nucleai and spatial proteomics-focused CRO Sirona Dx partnered to deliver AI-driven spatial proteomics services for biopharma. Sirona Dx will lead assay design, development and validation to improve assay data quality, while Nucleai applies AI analytics for feature extraction, biomarker discovery and interpretation. The collaboration is positioned as a way to streamline sponsors’ spatial biology workflows for clinical development programs.